Medicare GLP-1 Bridge Program: What It Is, Who Qualifies, and How to Access It
Medicare was not known to cover weight loss medications. This means that Medicare beneficiaries on GLP-1 medications had to face high out-of-pocket costs every month. However, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge Program. This pilot program will provide Medicare prescription plan beneficiaries access to weight-loss medications for a $50 monthly copayment.
The program requires your healthcare provider to submit a prior authorization with supporting medical documentation.
At NP2GO, our team has extensive experience prescribing GLP-1 medications and handling insurance prior authorizations. We are up to date with evolving Medicare requirements and well-versed in preparing and submitting the paperwork required for the Medicare GLP-1 Bridge Program.
In this guide, we'll explain how the Medicare GLP-1 Bridge Program works, who qualifies, which medications are covered, and how you can access it.
What Is the Medicare GLP-1 Bridge Program?
The Medicare GLP-1 Bridge program is a short-term pilot project established by CMS to help eligible Medicare Part D beneficiaries access certain GLP-1 medications (glucagon-like peptide-1) for weight management at a $50 monthly copay for a 28- or 30-day supply.
The program officially launched on July 1, 2026, and is currently scheduled to continue through December 31, 2027.
The program is designed to bridge the gap between the growing demand for obesity treatments and Medicare's historically limited coverage of anti-obesity medications.
Which GLP-1 Drugs Are Covered Under the Medicare GLP-1 Bridge Program?
The Medicare GLP-1 Bridge Program covers a select group of FDA-approved GLP-1s. Not every GLP-1 medication or formulation is covered.
As of the program's launch, CMS includes the following medications:
Foundayo (orforglipron): Oral tablet.
Wegovy (semaglutide): Both injection pens, including WegovyHD, and oral tablets.
Zepbound (tirzepatide): Only the KwikPen.
What drugs are not covered under the Medicare GLP-1 Bridge program?
Not all GLP-1s are eligible for the GLP-1 Bridge program. The following medications and formulations are not included:
Zepbound single-use vials or single-dose pens.
Ozempic (semaglutide), which is primarily indicated and covered under Part D for Type 2 diabetes management.
Any GLP-1 medications prescribed for indications already covered under standard Medicare Part D benefits, like Type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic metabolic dysfunction-associated steatohepatitis/MASH. In these cases, patients should use their regular Part D plan rather than the Bridge.
Off-label uses or compounded medications.
Can Any Medicare Beneficiary Participate?
Not every Medicare beneficiary is eligible for the Medicare GLP-1 Bridge Program. To participate, you must be prescribed a covered GLP-1 medication to reduce excess body weight and maintain weight loss. You must also meet the Medicare GLP-1 Bridge Program's clinical eligibility criteria and obtain approval through the required prior authorization process before coverage can begin.
You must also be enrolled in an eligible Medicare Part D prescription drug plan. The program is available to beneficiaries enrolled in standalone Medicare Part D Prescription Drug Plans (PDPs) and Medicare Advantage plans that include prescription drug coverage.
Beneficiaries enrolled in Special Needs Plans (SNPs), Employer/Union Group Waiver Plans (EGWPs), and the Limited Income Newly Eligible Transition (LI NET) program are also eligible to participate. People who qualify for both Medicare and Medicaid may participate if they are enrolled in an eligible Part D plan and meet the program's clinical requirements.
If you have other Medicare plan types, such as a Program of All-Inclusive Care for the Elderly (PACE), you may not be eligible for the Medicare GLP-1 Bridge Program unless you are also enrolled in a standalone Part D Prescription Drug Plan.
Who Is Eligible for the Medicare GLP-1 Bridge Program?
To be eligible, you must meet all the medical and lifestyle criteria of the program. All qualifying participants must be a minimum of 18 years old, prescribed a GLP-1 for reducing excess body weight and maintaining weight loss, and commit to lifestyle modifications. This includes diet and exercise that align with the FDA-approved label of the medication.
Your prescriber’s prior authorization document must also verify that you fulfill one of the following clinical criteria:
Have a BMI of 35 or higher, or
Have a BMI of 30 or higher with a diagnosis of one or more of these conditions: uncontrolled hypertension, diastolic heart failure, or chronic kidney disease Stage 3a or higher.
Have a BMI of 27 or higher with either pre-diabetes, symptomatic peripheral artery disease, or a previous myocardial infarction or stroke.
Who Is Not Eligible?
You may not qualify for the Bridge Program if your GLP-1 medication is already covered through Medicare Part D for another FDA-approved use.
The Bridge Program does not apply if you are taking a GLP-1 medication to treat Type 2 diabetes, moderate to severe obstructive sleep apnea, or metabolic dysfunction-associated steatohepatitis (MASH), even if you meet the Medicare GLP-1 Bridge clinical criteria.
You should continue to receive coverage through the standard Medicare Part D prescription drug benefit rather than through the Bridge Program. The Medicare GLP-1 Bridge is designed to increase access to GLP-1s for people who seek the drug solely to reduce excess body weight or maintain weight reduction.
How Does the Medicare GLP-1 Bridge Program Work?
Here are 6 steps of how the Medicare GLP-1 Bridge program works:
Schedule an evaluation with a healthcare provider
The first step is to meet with a healthcare provider experienced in obesity medicine and GLP-1 therapies. During your appointment with NP2GO, your provider will review your medical history, current medications, body mass index (BMI), and any weight-related health conditions to determine your eligibility for GLP-1 medication.
Your provider will also verify that you are enrolled in an eligible Medicare Part D plan and discuss whether you may qualify for the Medicare GLP-1 Bridge Program.
Confirm that you meet the program's eligibility requirements.
If a GLP-1 medication is appropriate, your provider will determine whether you meet the clinical criteria established by the CMS.
Your provider prescribes a covered GLP-1 medication
If you meet the eligibility criteria, your healthcare provider will prescribe a GLP-1 medication covered under the Bridge Program.
A prior authorization is submitted
Before Medicare will cover the medication, your provider must submit a prior authorization form through the Medicare GLP-1 Bridge Program.
Medicare reviews the request
Once the prior authorization has been submitted, CMS reviews the documentation to determine whether you qualify for the Medicare GLP-1 Bridge Program.
If additional information is needed, your healthcare provider may be asked to submit further documentation. Once the request is approved, you will also receive an email from Medicare confirming that your medicine is covered.
Fill your prescription
Fill your prescription at your pharmacy and pay $50 for a 28- or 30-day supply. You will not need a new approval from Medicare to get a refill as long as you stay on the same drug, even if your dose changes.
It’s important that you continue to work with your healthcare provider to monitor your progress, manage any side effects, and make adjustments to your treatment plan as needed.
FAQ About the Medicare GLP-1 Bridge Program
Does Medicare now cover GLP-1 medications for weight loss?
Medicare has historically not covered GLP-1 medications prescribed solely for weight loss. However, the Medicare GLP-1 Bridge Program provides short-term coverage for certain FDA-approved GLP-1 medications for eligible beneficiaries who meet the program's clinical criteria and are enrolled in a qualifying Medicare Part D plan.
How much does the Medicare GLP-1 Bridge Program cost?
Eligible beneficiaries pay a flat $50 monthly copayment for covered GLP-1 medications through the Medicare GLP-1 Bridge Program.
Is everyone with Medicare eligible for the Medicare GLP-1 Bridge Program?
No. Eligibility is limited to beneficiaries enrolled in eligible Medicare Part D plans who meet the clinical criteria for the Medicare GLP-1 Bridge Program's chronic weight management. You must also be prescribed a covered GLP-1 medication and receive prior authorization approval before your medication can be covered under the program.
Can my healthcare provider submit the prior authorization?
Yes. Your healthcare provider must submit the prior authorization. They are responsible for documenting your medical history, confirming that you meet the Medicare GLP-1 Bridge Program's eligibility criteria, and providing the supporting information CMS needs to determine whether your medication qualifies for coverage.
How NP2Go Can Help You Access the Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge Program provides a new option for beneficiaries enrolled in Medicare Part D prescription plans to obtain certain glucagon-like peptide-1 (GLP-1)
medications for weight loss with a monthly copay of $50. The Foundayo (orforglipron) tablet, Wegovy (semaglutide) injectable and oral medications, and the Zepbound (tirzepatide) KwikPens will be accessible through the program. To be eligible, you need to be signed up for specific Part D plans, meet clinical standards, and have a prescription for a GLP-1 medication for weight loss.
At NP2GO, our care team has extensive experience with GLP-1 medications for weight management. We are well-versed in the Medicare GLP-1 Bridge Program, including its eligibility criteria, covered medications, and prior authorization requirements.
We begin with a comprehensive evaluation to determine whether GLP-1 is the right option for you. If you qualify, we'll prescribe the medication and work with you to gather the documentation needed to support your prior authorization request.
We understand what Medicare requires and carefully prepare and submit prior authorization requests to help reduce the risk of delays caused by missing or incomplete information. If additional documentation is requested during the review process, our team will continue working on your behalf to help move your application forward.
We also provide ongoing support after your prescription is approved. As you begin treatment, we'll monitor your progress, address any questions or side effects, and adjust your treatment plan as needed to help you achieve your weight loss goals.
We offer telehealth services across 40 states, including Connecticut, Oklahoma, Delaware, Florida, Hawaii, Idaho, and more.
To find out if you qualify for the Medicare GLP-1 Bridge Program, schedule yourconsultation with NP2GO today. We'll help you understand your options, handle the paperwork, and guide you every step of the way so you can focus on achieving your health and weight loss goals.
